Author:
Becker Heiko,Suciu Stefan,Rüter Björn Hans,Platzbecker Uwe,Giagounidis Aristoteles,Selleslag Dominik,Labar Boris,Germing Ulrich,Salih Helmut R.,Muus Petra,Pflüger Karl-Heinz,Hagemeijer Anne,Schaefer Hans-Eckart,Fiaccadori Valeria,Baron Frédéric,Ganser Arnold,Aul Carlo,de Witte Theo,Wijermans Pierre W.,Lübbert Michael
Publisher
Springer Science and Business Media LLC
Subject
Hematology,General Medicine
Reference36 articles.
1. Greenberg P, Cox C, LeBeau MM et al (1997) International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood 89:2079–2088
2. Germing U, Gattermann N, Strupp C, Aivado M, Aul C (2000) Validation of the WHO proposals for a new classification of primary myelodysplastic syndromes: a retrospective analysis of 1600 patients. Leuk Res 24:983–992
3. Kantarjian H, Beran M, Cortes J et al (2006) Long-term follow-up results of the combination of topotecan and cytarabine and other intensive chemotherapy regimens in myelodysplastic syndrome. Cancer 106:1099–1109
4. Deschler B, de Witte T, Mertelsmann R, Lübbert M (2006) Treatment decision-making for older patients with high-risk myelodysplastic syndrome or acute myeloid leukemia: problems and approaches. Haematologica 91:1513–1522
5. Estey EH (2013) Epigenetics in clinical practice: the examples of azacitidine and decitabine in myelodysplasia and acute myeloid leukemia. Leukemia 27:1803–1812
Cited by
20 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献